Additional Mice definition

Additional Mice means (a) the mice developed by Kirin Brewery Company, Ltd. (“Kirin”) using certain transchromosomal technology and licensed to Medarex pursuant to the Collaboration and License Agreement between Medarex and Kirin, dated September 4, 2002 (the “Kirin Agreement”), and (b) the mice developed through the crossbreeding of the Medarex Mice with the mice described in clause (a) of this Section 1.1 and licensed to Medarex pursuant to the Kirin Agreement.
View Source

Examples of Additional Mice in a sentence

  • Subject to Section 20.1.2 of this Agreement, on a Research Antigen-by-Research Antigen basis, Medarex hereby grants to Genmab an option to expand the rights granted by Medarex to Genmab in the Research License during the applicable Research License Period with respect to a particular Research Antigen to include rights with respect to the Additional Technology and the Additional Mice (and Mice Materials derived from such Additional Mice) (each an “Additional Technology Research Option”).

  • Genmab may transfer Mice Materials derived from Additional Mice to Affiliates and third parties, subject to Section 3.4.1, Section 21.1.7, and the other terms and conditions of this Agreement.

  • In the event that Genmab conceives or develops any [***] to any Additional Mice in connection with the use of such Additional Mice and in violation of the terms of this Agreement, Genmab shall notify Medarex thereof and assign to Medarex any and all of Genmab’s right, title and interest in and to any such [***].

  • It is acknowledged and agreed by Medarex and Genmab that, subject to the limitations set forth in Section 16.3.1 in respect of Antibodies raised in the Additional Mice, there is [***] of Antibodies [***] of Bispecific Antibodies that may be included in any Exclusive Antibody License nor any limit to the number of Antibody Availability Notices that Genmab may provide with respect to any Exclusive Antibody License.

  • In each such written request, Genmab shall specify the number of [***]-Mice and/or [***] Mice that it wishes to be provided with Genmab and Medarex agree that Genmab shall have no right to breed or otherwise reproduce the Additional Mice.

  • With respect to the Additional Mice and the Additional Technology, in the event of any conflict between the terms and conditions of any such sublicense and the terms and conditions of the [***] the terms and conditions of [***] shall control.

  • With respect to the Additional Mice and the Additional Technology, each license granted by [***] to [***] under [***] and each sublicense granted by [***] to [***] under [***] and each further sublicense under such license or [***] granted by [***] pursuant to the terms of this Agreement, shall be [***].

  • Medarex and Pfizer shall, during the Contract Period, as a matter of course as described in the Research Plan, or upon each other’s written or oral request, furnish to each other samples of biochemical, biological or synthetic chemical materials which are part of Pfizer Technology, Medarex Technology or Program Technology;excluding HuMAb Mice, Additional Mice or other human antibody transgenic animals owned by Medarex.

  • Notwithstanding the foregoing, Medarex’s obligations to immunize Additional Mice on behalf of Pfizer shall be subject to the availability of Medarex’s supply of such Additional Mice.

Related to Additional Mice

  • Additional Members means those Members, if any, admitted to the Company after the Effective Date.

  • Additional Member means a Person admitted as a Member of the Company as a result of an issuance of Shares to such Person by the Company.

  • transitional matter means a matter that needs to be dealt with for the purpose of effecting the transition from the provisions of the Acts amended by this Act as in force before this Act comes into operation to the provisions of those Acts as in force after this Act comes into operation.

  • Additional Indication means any indication other than the Initial Indication.

  • Additional SDU Study means a deliverability study that a Developer may elect to pursue as that term is defined in OATT Section 25 (OATT Attachment S).